A股異動 | 銀江股份(300020.SZ)漲超4% 控股股東擬轉讓3278.95萬股予中證乾元基金
格隆匯8月20日丨銀江股份(300020.SZ)現報11.29元,漲4.34%,暫成交1.2億元,最新總市值74億元。銀江股份昨日盤後公佈,公司於近日收到公司控股股東銀江科技集團的通知,獲悉其與中證乾元四世同堂傳承複利1號私募證券投資基金(“中證乾元基金”或“受讓方”)於2020年8月17日簽訂了《股份轉讓協議》,銀江科技集團將其持有的3278.95萬股無限售流通股份以10.134元/股(人民幣,下同)的價格轉讓給中證乾元基金。本次股權轉讓的實施不會導致公司控制權發生變更。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.